ArticleDrug and alcohol dependence2025
Cannabis use disorder risks among Medicaid enrollees with comorbid psychiatric illnesses: 2012-2021.
Article in Drug and alcohol dependence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
objectivesTo examine trends in prevalence of cannabis use disorder (CUD) among Medicaid enrollees with and without comorbid psychiatric illnesses - depression, anxiety, or insomnia - overall and by sex and age subgroups.
methodsMedicaid enrollees aged 18-64 in the Merative Multi-state Claims and Encounters Database with diagnoses of CUD and comorbid psychiatric illnesses - depression, anxiety, or insomnia - from 2012 to 2021 were examined using a multi-variate logit regression adjusting for sex, age, and race. Additionally, CUD and comorbid chronic pain diagnosis for the same population were examined as a comparison. We estimated the changes in the prevalence of CUD among enrollees with and without depression, anxiety, or insomnia.
resultsFrom 2012-2021, the predicted prevalence of CUD among enrollees with depression, anxiety, and insomnia as a comorbidity increased by 1.04 (p < 0.001), 1.36 (p < 0.001), 1.64 (p < 0.001) times compared to the enrollees without those comorbidities, respectively, while the predicted prevalence of CUD among enrollees with chronic pain reduced by 0.90 (p < 0.001) times compared to those without chronic pain. Relative increases in the predicted prevalence of CUD were higher among females and those aged 35-64 with anxiety and depression, and among males and those aged 21-34 with insomnia.
conclusionsMedicaid enrollees with depression, anxiety, or insomnia were increasingly more likely to experience CUD diagnoses for the past decade compared to those without the condition. Further research is needed to understand the mechanism between cannabis use and psychiatric illnesses and curb the rising CUD associated with comorbid psychiatric illnesses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.